Oncocyte Corp (OCX): 9 insider purchases in the last two years (1 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 11, 2025 | Smith Patrick W TenPercentOwner | 1,077,600 | $2.05 | $2.2M | no history |
| Feb 11, 2025 | James Andrea S. Officer | 97,561 | $2.05 | $200.0K | no history |
| Feb 10, 2025 | Broadwood Partners, L.P. TenPercentOwner | 5,165,695 | $2.05 | $10.6M | opportunistic |
| Feb 4, 2025 | Smith Patrick W TenPercentOwner | 915 | $2.01 | $1.8K | no history |
| Jan 31, 2025 | Smith Patrick W TenPercentOwner | 4,198 | $2.01 | $8.4K | no history |
| Jan 15, 2025 | Smith Patrick W TenPercentOwner | 16,055 | $2.12 | $34.1K | no history |
| Dec 27, 2024 | Smith Patrick W TenPercentOwner | 90,219 | $2.13 | $192.2K | no history |
| Dec 26, 2024 | Arno Andrew Director | 12,500 | $2.11 | $26.4K | no history |
| Dec 9, 2024 | James Andrea S. Officer | 20,000 | $2.29 | $45.8K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.